SAF Stock Analysis: Safran | PA
Aerospace & Defense | PA, France | Market Cap: 146.330m EUR | 12M Return: 18.6% | FR0000073272 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 153M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Safran SA is a French-headquartered aerospace and defense company that operates globally across three segments: Aerospace Propulsion; Aircraft Equipment, Defense and Aerosystems; and Aircraft Interiors. Its products and services are used in commercial and military aircraft and helicopters, with operations spanning Europe, the Americas, Asia-Pacific, Africa, and the Middle East.
The Aerospace Propulsion segment designs and produces propulsion and mechanical power transmission systems, as well as offering maintenance, repair, and overhaul (MRO) services and spare parts. Propulsion is a high-barrier sector given lengthy certification cycles, significant capital requirements for new engine programs, and the industrys reliance on long-cycle joint ventures between OEMs. MRO and spare parts provide a recurring aftermarket revenue stream tied to the installed base of engines already in service.
The Aircraft Equipment, Defense and Aerosystems segment supplies landing gear, brakes, nacelles, avionics, and various onboard systems, while the Aircraft Interiors segment produces cabin equipment including seating, galleys, lavatories, and in-flight entertainment and connectivity solutions. Founded in 1896 and headquartered in Paris, Safran is listed on Euronext Paris (ticker: SAF) and is classified as a large-cap Industrials stock within the Aerospace & Defense sub-industry.
- LEAP engine deliveries drive Aerospace Propulsion revenue growth
- Aftermarket services margins expand with rising global flight hours
- Aircraft Interiors margins recover post-Zodiac integration and restructuring
- Airbus and Boeing production rate increases boost OE demand
| Net Income: 3.88b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.60 > 1.0 |
| NWC/Revenue: -13.94% < 20% (prev -8.53%; Δ -5.41% < -1%) |
| CFO/TA 0.10 > 3% & CFO 6.70b > Net Income 3.88b |
| Net Debt (-413.0m) to EBITDA (5.85b): -0.07 < 3 |
| Current Ratio: 0.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (415.5m) vs 12m ago -5.08% < -2% |
| Gross Margin: 13.67% > 18% (prev 31.78%; Δ -18.11% > 0.5%) |
| Asset Turnover: 54.81% > 50% (prev 52.22%; Δ 2.60% > 0%) |
| Interest Coverage Ratio: 33.02 > 6 (EBIT TTM 4.26b / Interest Expense TTM 129.0m) |
| A: -0.07 (Total Current Assets 40.1b - Total Current Liabilities 44.8b) / Total Assets 66.4b |
| B: 0.19 (Retained Earnings 12.4b / Total Assets 66.4b) |
| C: 0.07 (EBIT TTM 4.26b / Avg Total Assets 61.2b) |
| D: 0.28 (Book Value of Equity 14.5b / Total Liabilities 51.3b) |
| Altman-Z'' = 0.91 = BB |
| DSRI: 1.18 (Receivables 19.4b/14.4b, Revenue 33.6b/29.3b) |
| GMI: 2.32 (GM 31.78% / 13.67%) |
| AQI: 0.56 (AQ_t 0.16 / AQ_t-1 0.28) |
| SGI: 1.15 (Revenue 33.6b / 29.3b) |
| TATA: -0.04 (NI 3.88b - CFO 6.70b) / TA 66.4b) |
| Beneish M = -1.84 (Cap -4..+1) = B |
As of August 26, 2026, the stock is trading at EUR 339.90 with a total of 377,381 shares traded. Over the past week, the price has changed by -5.87%, over one month by +3.06%, over three months by +14.00% and over the past year by +18.56%.
Current recommended Stop Loss: 329.30 (which is 3.1% or 1.3 ATR below the current price).
Safran has no consensus analysts rating.
P/E Trailing = 36.9066
P/E Forward = 32.7869
P/S = 4.2418
P/B = 9.8122
P/EG = 2.3441
Revenue TTM = 33.6b EUR
EBIT TTM = 4.26b EUR
EBITDA TTM = 5.85b EUR
Long Term Debt = 2.04b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.24b EUR (from shortTermDebt, last quarter)
Debt = 6.09b EUR (from shortLongTermDebtTotal, last quarter) + Leases 987.0m
Net Debt = -413.0m EUR (calculated: Debt 6.09b - CCE 6.51b)
Enterprise Value = 146b EUR (146b + Debt 6.09b - CCE 6.51b)
Interest Coverage Ratio = 33.02 (Ebit TTM 4.26b / Interest Expense TTM 129.0m)
EV/FCF = 27.89x (Enterprise Value 146b / FCF TTM 5.23b)
FCF Yield = 3.59% (FCF TTM 5.23b / Enterprise Value 146b)
FCF Margin = 15.59% (FCF TTM 5.23b / Revenue TTM 33.6b)
Net Margin = 11.56% (Net Income TTM 3.88b / Revenue TTM 33.6b)
Gross Margin = 13.67% ((Revenue TTM 33.6b - Cost of Revenue TTM 29.0b) / Revenue TTM)
Gross Margin QoQ = 15.15% (prev 12.10%)
Tobins Q-Ratio = 2.20 (Enterprise Value 146b / Total Assets 66.4b)
Interest Expense / Debt = 2.12% (Interest Expense 129.0m / Debt 6.09b)
Taxrate = 31.47% (1.82b / 5.80b)
NOPAT = 2.92b (EBIT 4.26b * (1 - 31.47%))
Current Ratio = 0.90 (Total Current Assets 40.1b / Total Current Liabilities 44.8b)
Debt / Equity = 0.42 (Debt 6.09b / totalStockholderEquity, last quarter 14.5b)
Debt / EBITDA = -0.07 (Net Debt -413.0m / EBITDA 5.85b)
Debt / FCF = -0.08 (Net Debt -413.0m / FCF TTM 5.23b)
Total Stockholder Equity = 13.2b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.34% (Net Income 3.88b / Total Assets 66.4b)
RoE = 29.44% (Net Income TTM 3.88b / Total Stockholder Equity 13.2b)
RoCE = 27.98% (EBIT 4.26b / Capital Employed (Equity 13.2b + L.T.Debt 2.04b))
RoIC = 13.18% (NOPAT 2.92b / Invested Capital 22.1b)
WACC = 8.05% (E(146b)/V(152b) * Re(8.33%) + D(6.09b)/V(152b) * Rd(2.12%) * (1-Tc(0.31)))
Discount Rate = 8.33% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.55 | Cagr: -1.16%
[DCF] Terminal Value 77.97% ; FCFF base≈4.77b ; Y1≈5.47b ; Y5≈8.05b
[DCF] Fair Price = 293.3 (EV 121b - Net Debt -413.0m = Equity 122b / Shares 414.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 99.86 | Revenue CAGR: 14.67% | SUE: 1.45 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=10.42 | Chg30d=+3.12% | Revisions=+47% | GrowthEPS=+37.1% | GrowthRev=+16.5%
EPS next Year (2027-12-31): EPS=13.07 | Chg30d=+5.31% | Revisions=+83% | GrowthEPS=+25.4% | GrowthRev=+9.9%
[Analyst] Revisions Ratio: +72% (up=26, down=3)